Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfeffer

Showing results (511-520 of 513) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 513 results.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Activation of PP2A-B56α leads to aberrant EGFR signaling and proliferative phenotypes in PDACClaire M Pfeffer, Sydney J Clifford, Saadia A Karim, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 6, 2009
[Rodents and rodent associated disease vectors: the network of "rodent carrying pathogens" introduces itself]R G Ulrich, G Heckel, H-J Pelz, et al.
American Heart Journal|June 20, 2006
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events, , S Connolly, et al.
Pageof 52

Showing results (511-520 of 513) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 513 results.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Activation of PP2A-B56α leads to aberrant EGFR signaling and proliferative phenotypes in PDACClaire M Pfeffer, Sydney J Clifford, Saadia A Karim, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 6, 2009
[Rodents and rodent associated disease vectors: the network of "rodent carrying pathogens" introduces itself]R G Ulrich, G Heckel, H-J Pelz, et al.
American Heart Journal|June 20, 2006
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events, , S Connolly, et al.
Pageof 52